While ratings are subjective and will change, the latest Regenxbio (RGNX) rating was a reiterated with a price target of $ to $ The current price. Latest After-Hours Trades ->. After Hours Time (ET). After Hours Price. After Hours Share Volume. Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing. According to our current RGNX stock forecast, the value of REGENXBIO shares will rise by % and reach $ per share by June 23, RGNX - Regenxbio - Stock Forecast RGNX is currently covered by 9 analysts with an average price target of $ This is a potential upside of $ (
As on 26th Jul RGNX STOCK Price closed @ and we RECOMMEND N/A for LONG-TERM with Stoploss of & N/A for SHORT-TERM with Stoploss of we also. Cash and Debt Metrics ; Consensus Recommendation. Buy ; Consensus Price. ; Range of Price Targets. to ; Range of EPS. to ; Consensus. Regenxbio started at buy with $35 stock price target at Stifel. Nov. 1, at a.m. ET by Tomi Kilgore. Read full story. Biotech and Pharma Gene Therapy. Investing. -$k ; Financing. -$M ; Regenxbio Stock FAQ · Regenxbio stock was originally listed at a price of $ in Sep 17, Approval of a Game-Changing Gene Therapy for SMA Delivers a Win for Novartis and Regenxbio A $ million price tag could make Zolgensma a blockbuster. The average one-year price target for REGENXBIO Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target is the. On average, Wall Street analysts predict that Regenxbio's share price could reach $ by Sep 4, The average Regenxbio stock price prediction forecasts. Based on the Regenxbio Inc stock forecast from 7 analysts, the average analyst target price for Regenxbio Inc is USD over the next 12 months. Regenxbio. The 9 analysts with month price forecasts for REGENXBIO stock have an average target of , with a low estimate of 21 and a high estimate of The. The current price of RGNX is USD — it has increased by % in the past 24 hours. Watch REGENXBIO Inc. stock price performance more closely on the chart.
Research REGENXBIO's (Nasdaq:RGNX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Find the latest REGENXBIO Inc. (RGNX) stock quote, history, news and other Lowering target price to $ REGENXBIO INC has an Investment Rating. Exchange. NASDAQ-GS ; Sector. Health Care ; Industry. Biotechnology: Biological Products (No Diagnostic Substances) ; 1 Year Target. $ ; Today's High/Low. Whether you're looking for tomorrow's prediction or the long-term outlook, these insights are invaluable. By examining forecasts from various credible sources. Consensus Recommendation. Buy ; Consensus Price. ; Range of Price Targets. to ; Range of EPS. to ; Consensus EPS. Stock price target for REGENXBIO Inc. RGNX are on downside and on upside. Stock price target for REGENXBIO Inc. RGNX are on downside and View REGENXBIO, Inc. RGNX stock quote prices, financial information, real-time forecasts, and company news from CNN. According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for REGENXBIO is $, with a. Get Regenxbio Inc (RGNX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Zacks' proprietary data indicates that REGENXBIO Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the RGNX shares relative. RegenXBio (RGNX) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. We've gathered opinions of 9 analysts rating RGNX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other. Regenxbio Inc Stock (RGNX) Price Forecast for Regenxbio Inc Stock (RGNX) is expected to reach an average price of $ in , with a high forecast of. Analyst. Target Price. · 11 analysts ; Earnings. EPS Forecast. Down. Next quarter ; Investor. New Investor. Avidity Partners Management Lp. +% Portfolio.